Accolade

Accolade FCF Yield

Delisted

The Free Cash Flow Yield of Accolade (ACCD) as of Oct 11, 2026 is -4.98 %. In the previous year, Free Cash Flow Yield was -8.33 % — a change of -40.23% (higher).

FCF Yield

-4.98 %

YoY

-40.23%

Last updated:

Free Cash Flow Yield of Accolade is 2024 -4.98 % . Free Cash Flow Yield of Accolade was 2023 -8.33 % . It decreases by -40.23% higher compared to the previous year.

The Accolade FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2018
-7.89 USD
Jan 1, 2019
-3.42 USD
Jan 1, 2020
-6.53 USD
Jan 1, 2021
-4.79 USD
Jan 1, 2022
-11.46 USD
Jan 1, 2023
-8.33 USD
Jan 1, 2024
-4.98 USD
The Accolade FCF Yield history
YEARFCF YieldYoY
-4.98 %-40.23%
-8.33 %-27.34%
-11.46 %+139.04%
-4.79 %-26.53%
-6.53 %+91.00%
-3.42 %-56.72%
-7.89 %—
Access this data via the Eulerpool API

Accolade Stock analysis

What does Accolade do? Accolade Inc is a US-American company based in Seattle. The company was founded in 2007 by Rajeev Singh and Mike Hilton and has since developed into a leading healthcare consulting firm. Accolade aims to make healthcare simple and affordable for everyone. The company offers a wide range of solutions to its customers. It provides services to employers, insurance companies, and health authorities. Their main focus is on supporting patients and employees in their healthcare. They also offer services to health insurance companies and health authorities. The business model of Accolade involves close collaboration between the customers and the company. Patients are supported by a "Health Assistant," who are trained professionals that help patients make the best decisions regarding their health. Factors such as finding the best providers, medication delivery, clinical tests, and alternative options are considered. Accolade's mission is to improve healthcare for everyone by providing the best solutions. The company has divided itself into several different divisions to offer its services more effectively. The various divisions of Accolade include healthcare consulting, medication management, patient access and health navigation, client support, and health optimization. Accolade has become an important healthcare service provider and has earned a good reputation in the industry. The company is known for providing comprehensive and high-quality services that focus on individual patient care. When it comes to achieving improvements in care and the entire healthcare system, Accolade is an important partner that helps companies and individuals achieve their goals and lead healthier lives. Accolade is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Accolade stock

Free Cash Flow Yield of Accolade is -4.98 % in 2024.

Free Cash Flow Yield of Accolade changed from -8.33 % to -4.98 %, representing a -40.23% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield Accolade since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's Accolade with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Accolade

All Key Metrics — Accolade